Hanmi reveals total 23 pipelines consisting of 14 biologics and 9 synthesized drugs

Published: 2017-04-11 14:57:03

Updated: 2017-04-11 14:57:03

Hanmi Pharm(CEO Sae-Chang Kwon & Jong-Soo Woo) revealed the development status(hereinafter referring to pipeline) of 23 new drugs which are currently being developed now in 2017.

The company explained the purpose of the update is to exercise ‘trust management,’ the company’s goal, and to create the sound investment culture by revealing accurate information to the nation and shareholders.

The ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.